sesamin has been researched along with Colonic Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kang, SS; Kim, WK; Lee, MA; Lee, SK; Park, HJ | 1 |
Arumugam, N; Bhandare, VV; Cavuturu, BM; Ramaswamy, A | 1 |
Kobayashi, D; Kuribayashi, K; Tanabe, H; Tanaka, M; Tsuji, N; Watanabe, N | 1 |
3 other study(ies) available for sesamin and Colonic Neoplasms
Article | Year |
---|---|
Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Axin Protein; beta Catenin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Flavonolignans; Humans; Lignans; Lonicera; RNA Interference; RNA, Small Interfering; Wnt Proteins; Wnt Signaling Pathway | 2013 |
Molecular dynamics of interaction of Sesamin and related compounds with the cancer marker β-catenin: an in silico study.
Topics: beta Catenin; Binding Sites; Colonic Neoplasms; Computer Simulation; Dioxoles; Humans; Lignans; Models, Molecular; Molecular Docking Simulation; Protein Binding; Protein Conformation; Transcription Factor 4 | 2019 |
Sesamin induces autophagy in colon cancer cells by reducing tyrosine phosphorylation of EphA1 and EphB2.
Topics: Antineoplastic Agents; Autophagy; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Dioxoles; Gene Silencing; HT29 Cells; Humans; Lignans; Phosphorylation; Receptor, EphA1; Receptor, EphB2; Tyrosine | 2011 |